These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 29760186
1. Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling. Robinson P, Liu X, Sparrow A, Patel S, Zhang YH, Casadei B, Watkins H, Redwood C. J Biol Chem; 2018 Jul 06; 293(27):10487-10499. PubMed ID: 29760186 [Abstract] [Full Text] [Related]
2. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca2+, and activate NFAT and Akt signaling. Robinson P, Sparrow AJ, Patel S, Malinowska M, Reilly SN, Zhang YH, Casadei B, Watkins H, Redwood C. Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H306-H319. PubMed ID: 32618513 [Abstract] [Full Text] [Related]
3. Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy. Helms AS, Alvarado FJ, Yob J, Tang VT, Pagani F, Russell MW, Valdivia HH, Day SM. Circulation; 2016 Nov 29; 134(22):1738-1748. PubMed ID: 27688314 [Abstract] [Full Text] [Related]
4. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins. Alves ML, Dias FAL, Gaffin RD, Simon JN, Montminy EM, Biesiadecki BJ, Hinken AC, Warren CM, Utter MS, Davis RT, Sakthivel S, Robbins J, Wieczorek DF, Solaro RJ, Wolska BM. Circ Cardiovasc Genet; 2014 Apr 29; 7(2):132-143. PubMed ID: 24585742 [Abstract] [Full Text] [Related]
5. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca2+ flux caused by thin filament hypertrophic cardiomyopathy mutations. Sparrow AJ, Watkins H, Daniels MJ, Redwood C, Robinson P. Am J Physiol Heart Circ Physiol; 2020 Mar 01; 318(3):H715-H722. PubMed ID: 32083971 [Abstract] [Full Text] [Related]
6. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models. Ferrantini C, Coppini R, Pioner JM, Gentile F, Tosi B, Mazzoni L, Scellini B, Piroddi N, Laurino A, Santini L, Spinelli V, Sacconi L, De Tombe P, Moore R, Tardiff J, Mugelli A, Olivotto I, Cerbai E, Tesi C, Poggesi C. J Am Heart Assoc; 2017 Jul 22; 6(7):. PubMed ID: 28735292 [Abstract] [Full Text] [Related]
13. Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes. Schuldt M, Johnston JR, He H, Huurman R, Pei J, Harakalova M, Poggesi C, Michels M, Kuster DWD, Pinto JR, van der Velden J. J Mol Cell Cardiol; 2021 Jan 01; 150():77-90. PubMed ID: 33148509 [Abstract] [Full Text] [Related]
14. Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers. Mickelson AV, Chandra M. Am J Physiol Heart Circ Physiol; 2017 Dec 01; 313(6):H1180-H1189. PubMed ID: 28842439 [Abstract] [Full Text] [Related]